Head to Head Review: CAS Medical Systems (CASM) vs. Its Peers


CAS Medical Systems (NASDAQ: CASM) is one of 106 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare CAS Medical Systems to similar businesses based on the strength of its dividends, earnings, valuation, profitability, analyst recommendations, risk and institutional ownership.

Volatility & Risk

Get CAS Medical Systems alerts:

CAS Medical Systems has a beta of -0.56, suggesting that its share price is 156% less volatile than the S&P 500. Comparatively, CAS Medical Systems’ peers have a beta of 0.77, suggesting that their average share price is 23% less volatile than the S&P 500.


Institutional & Insider Ownership

22.7% of CAS Medical Systems shares are owned by institutional investors. Comparatively, 49.0% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 37.6% of CAS Medical Systems shares are owned by company insiders. Comparatively, 16.0% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.


Profitability

This table compares CAS Medical Systems and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CAS Medical Systems -9.72% N/A -40.08%
CAS Medical Systems Competitors -75.27% -79.19% -19.44%

Analyst Ratings

This is a breakdown of current ratings and target prices for CAS Medical Systems and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CAS Medical Systems 0 0 0 0 N/A
CAS Medical Systems Competitors 541 2020 3925 148 2.55

As a group, “Surgical & medical instruments” companies have a potential upside of 2.62%. Given CAS Medical Systems’ peers higher probable upside, analysts plainly believe CAS Medical Systems has less favorable growth aspects than its peers.

Valuation & Earnings

This table compares CAS Medical Systems and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CAS Medical Systems $18.76 million -$2.33 million -5.74
CAS Medical Systems Competitors $1.51 billion $110.16 million -211.68

CAS Medical Systems’ peers have higher revenue and earnings than CAS Medical Systems. CAS Medical Systems is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

CAS Medical Systems peers beat CAS Medical Systems on 6 of the 10 factors compared.

CAS Medical Systems Company Profile

CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

Leave a Reply

Your email address will not be published. Required fields are marked *